MAY 21 3PostersMonday AfternoonMorning9:00 AM – 5:15 PM • Rhinel<strong>and</strong>er GalleryCellular Mechanisms (Cell Biology;Cell Membrane Transport/Ion Channels;Coagulation/Thrombosis; GrowthFactors)PO-217: 1PO-218: 1PO-219: 2Transforming Growth Factor-β (TGF-β)-mediatedthe Down-Regulation of Peroxisome Proliferator-Activated Receptorγ (PPARγ) in the PressureOverloaded HeartKaizheng Gong, Peng Li, Jason Lucas, Dongqi Xing,Baran Aksut, Fadi Hage, Qinglin Yang, Susan E. Nozell,Suzanne Oparil, Yiu-Fai Chen. Vascular Biology <strong>and</strong>Hypertension Program, University of Alabama atBirmingham, US.Serum Phosphate in White Coat HypertensivePatients: Focus on Dipping Status <strong>and</strong> MetabolicSynromeV. Tzamou, 1 G. Vyssoulis, 1 E. Karpanou, 2 Stella-Maria Kyvelou, 1 T. Gialernios, 1 C. Stefanadis. 1 1 1stCardiology Clinic Athens University HippokrationHospital, GR <strong>and</strong> 2 Cardiology Clinic OnassisCardiosurgery Center, GR.Regulation of Manganese Superoxide DismutaseExpression in Cardiac Fibroblasts by Angiotensin IIPaul J. Lijnen, Robert H. Fagard. University of Leuven(KULeuven), Leuven, BE.Clinical TrialsPO-220: 1PO-221: 3Optimal Blood Pressure Control <strong>and</strong> All CauseMortality in a Clinical Practice SettingVasilios Papademetriou, 1 Richard Amdur, 1 MichaelDoumas, 2 Costas Tsioufis, 1 Peter Kokkinos, 1 CharlesFaselis, 2 Ross D. Fletcher. 1 1 VAMC <strong>and</strong> GeorgetownUniversity, Washington, DC, US; 2 VAMC <strong>and</strong> GeorgeWasgington University, US; 3 VAMC <strong>and</strong> GeorgetownUniversity, US; 4 VAMC <strong>and</strong> Georgetown University,US <strong>and</strong> 5 VAMC <strong>and</strong> Georgetown University, US.Effects of the Novel Angiotensin Receptor BlockerAzilsartan Medoxomil in Patients with PrimaryHypertensionGeorge Bakris†, 1 Domenic Sica, 2 Michael Weber, 3William B. White, 4 Alfonso Perez, 5 Charlie Cao, 5Stuart Kupfer. 5 1 University of Chicago, PritzkerSchool of Medicine, Chicago, IL, US; 2 VirginiaCommonwealth University Health System, Richmond,VA, US; 3 SUNY Downstate College of Medicine,New York, NY, US; 4 Univ. of Connecticut School ofMedicine, Farmington, CT, US <strong>and</strong> 5 Takeda GlobalResearch & Development, Deerfield, IL, US.1 Pathobiology Track 2 Translational Track 3 Therapy Track142
Monday Morning Afternoon MAY 21 3PostersPO-222: 3PO-223: 3PO-224: 3PO-225: 3PO-226: 3PO-227: 3PO-228: 3PO-229: 3PO-230: 3Efficacy <strong>and</strong> Safety of Nebivolol in Patients withStage II Hypertension: Pooled Results From ThreePhase III TrialsLynn Denekamp†, Phillip Jennings. Forest ResearchInstitute, Jersey City, NJ, US.Aliskiren: Will a Novel Mechanism Improve ClinicalOutcomes?MariaLeonarda DeRosa. Dept.of Cardiology Universityof Naples Federico II, Naples, Na, IT.Human Blood Pressure Readings are More Accurate<strong>and</strong> Show Less Variation than Oscillometric DeviceReadingsClarence E. Grim, 2 Carlene M. Grim. 1 1 Shared CareResearch <strong>and</strong> Education Consulting, Inc., Milwaukee,WI, US <strong>and</strong> 2 High Blood Pressure Consulting,Milwaukee, WI, US.A Phase IV, Prospective, R<strong>and</strong>omized, Double-Blind, Placebo-Controlled Study of NebivololWithdrawal in Patients with Stage I-II HypertensionKati Gutierrez†, 1 Fang Dong, 1 Cristian F. Breton. 21 Forest Research Institute, Jersey City, NJ, US <strong>and</strong>2 International Research Associates, Miami, FL, US.Improved Renal Function Associated with theNormalization of the Circadian Blood PressurePattern by Angiotensin Receptor BlockadeRamon C. Hermida, Diana E. Ayala, Artemio Mojon,Jose R. Fern<strong>and</strong>ez. University of Vigo, ES.Improved Ambulatory Pulse Pressure Reductionwith Bedtime as Compared to MorningAdministration of Nifedipine GITS in EssentialHypertensionRamon C. Hermida, 1 Diana E. Ayala, 1 Luisa Chayan, 2Maria J. Fontao, 1 Artemio Mojon, 1 Jose R. Fern<strong>and</strong>ez. 11 University of Vigo, ES <strong>and</strong> 2 Urgencias Sanitarias 061Galicia, ES.Treatment of Non-Dipper Essential Hypertension byBedtime Administration of Angiotensin ReceptorBlockersRamon C. Hermida, Diana E. Ayala, Maria J. Fontao,Artemio Mojon, Jose R. Fern<strong>and</strong>ez. University of Vigo,ES.Increasing the Awake/Asleep Blood PressureRatio Towards a More Dipping Pattern ReducesCardiovascular Risk: Results of the MAPEC StudyRamon C. Hermida, 1 Diana E. Ayala, 1 ArtemioMojon, 1 Maria J. Fontao, 1 Rita Soler, 1 Luisa Chayan, 2Ignacio Alonso, 1 Jose R. Fern<strong>and</strong>ez. 1 1 University ofVigo, ES <strong>and</strong> 2 Urgencias Sanitarias 061 Galicia, ES.Influence of Circadian Time of AntihypertensiveTreatment on Cardiovascular Risk: Results of theMAPEC StudyRamon C. Hermida, 1 Diana E. Ayala, 1 ArtemioMojon, 1 Maria J. Fontao, 1 Rita Soler, 1 Luisa Chayan, 2Ignacio Alonso, 1 Jose R. Fern<strong>and</strong>ez. 1 1 University ofVigo, ES <strong>and</strong> 2 Urgencias Sanitarias 061 Galicia, ES.1 Pathobiology Track 2 Translational Track 3 Therapy Track143
- Page 1 and 2:
American Society of Hypertension201
- Page 3 and 4:
Valturna offers bothsuperior BP eff
- Page 5 and 6:
Figure 2: Probability of Achieving
- Page 7 and 8:
potential for other drugs acting on
- Page 9 and 10:
aliskiren arms were about one-third
- Page 11 and 12:
As with other drugs that block angi
- Page 13:
American Society of Hypertension201
- Page 18:
Program Color KeyThe pages of this
- Page 21 and 22:
General InformationThis program boo
- Page 23 and 24:
General Information continuedHilton
- Page 25 and 26:
General Information continuedASH Sc
- Page 27 and 28:
General Information continuedASH Hy
- Page 29 and 30:
2010 ASH Corporate MembersBoehringe
- Page 31 and 32:
ASH Leadership2009-2010 Board of Di
- Page 33 and 34:
Special LectureMonday, May 3, 2010,
- Page 35 and 36:
Special LectureMonday, May 3, 2010,
- Page 37 and 38:
2010 Abstract Reviewers continuedEr
- Page 39 and 40:
Visit TEKTURNA at Booth 1100.and/or
- Page 41 and 42:
5.5 HyperkalemiaIncreases in serum
- Page 43 and 44:
with Pgp substrates or weak to mode
- Page 45 and 46:
ASH Program at a GlanceSaturday, Ma
- Page 47 and 48:
ASH Program at a GlanceMonday, May
- Page 49 and 50:
Poster Category PresentationPosters
- Page 51 and 52:
2010 ASH Faculty continuedJeffrey R
- Page 53 and 54:
2010 ASH Faculty continuedAndrew Wh
- Page 55 and 56:
2010American Societyof Hypertension
- Page 57 and 58:
Saturday Afternoon MAY 1PostersPost
- Page 59 and 60:
Saturday Afternoon MAY 1Sessions3:3
- Page 61 and 62:
Saturday Afternoon MAY 1Sessions3:3
- Page 63 and 64:
Sunday Morning MAY 2Satellite Sympo
- Page 65 and 66:
Sunday Morning MAY 2Sessions contin
- Page 67 and 68:
Sunday Morning MAY 2Sessions8:00 AM
- Page 69 and 70:
Sunday Morning MAY 2Sessions10:00 A
- Page 71 and 72:
Sunday Morning MAY 2Sessions10:00 A
- Page 73 and 74:
Sunday Afternoon MAY 2Sessions3:30
- Page 75 and 76:
Sunday Afternoon MAY 2Sessions3:30
- Page 77 and 78:
Sunday Afternoon MAY 2Special Sessi
- Page 79 and 80:
Sunday Evening MAY 2Sessions6:00 PM
- Page 81 and 82:
Sunday Evening MAY 2Sessions6:00 PM
- Page 83 and 84:
Monday Morning MAY 3Satellite Sympo
- Page 85 and 86:
Monday Morning MAY 3Sessions8:00 AM
- Page 87 and 88:
Monday Morning Afternoon MAY 21 3Po
- Page 89 and 90:
Monday Morning MAY 3Sessions10:00 A
- Page 91 and 92:
Monday Morning MAY 3Sessions10:00 A
- Page 93 and 94: Monday Morning MAY 3Sessions11:45 A
- Page 95 and 96: Monday Evening May 3Satellite Sympo
- Page 97 and 98: Tuesday Morning May 48:45 AM LB-OR-
- Page 99 and 100: Tuesday Morning May 4Sessions8:00 A
- Page 101 and 102: Tuesday Morning MAY 4ASH Membership
- Page 103 and 104: Tuesday Morning MAY 4Sessions10:55
- Page 105 and 106: 2010American Societyof Hypertension
- Page 107 and 108: Saturday Afternoon MAY 1Posters3:00
- Page 109 and 110: Saturday Afternoon MAY 1PostersPO-2
- Page 111 and 112: Saturday Afternoon MAY 1PostersPO-3
- Page 113 and 114: Saturday Afternoon MAY 1PostersPO-4
- Page 115 and 116: Saturday Afternoon MAY 1PostersPO-5
- Page 117 and 118: Saturday Afternoon MAY 1PostersPO-7
- Page 119 and 120: Saturday Afternoon MAY 1PostersPO-8
- Page 121 and 122: Saturday Afternoon MAY 1PostersPO-9
- Page 123 and 124: Saturday Afternoon MAY 1PostersPO-1
- Page 125 and 126: Sunday Morning MAY 2PostersPosters
- Page 127 and 128: Sunday Morning MAY 2Posters9:00 AM
- Page 129 and 130: Sunday Morning MAY 2PostersPO-123:
- Page 131 and 132: Sunday Morning MAY 2PostersPO-137:
- Page 133 and 134: Sunday Morning MAY 2PostersPO-150:
- Page 135 and 136: Sunday Morning MAY 2PostersPO-163:
- Page 137 and 138: Sunday Morning MAY 2PostersPO-178:
- Page 139 and 140: Sunday Morning MAY 2PostersPO-193:
- Page 141 and 142: Sunday Morning MAY 2PostersPO-206:
- Page 143: Monday Morning Afternoon MAY 21 3Po
- Page 147 and 148: Monday Morning Afternoon MAY 21 3Po
- Page 149 and 150: Monday Morning Afternoon MAY 21 3Po
- Page 151 and 152: Monday Morning Afternoon MAY 21 3Po
- Page 153 and 154: Monday Morning Afternoon MAY 21 3Po
- Page 155 and 156: Monday Morning Afternoon MAY 21 3Po
- Page 157 and 158: Monday Morning Afternoon MAY 21 3Po
- Page 159 and 160: Monday Morning Afternoon MAY 21 3Po
- Page 161 and 162: Monday Morning Afternoon May 213Pos
- Page 163 and 164: Faculty Disclosure ListingGail Adle
- Page 165 and 166: Faculty Disclosure Listing continue
- Page 167 and 168: Faculty Disclosure Listing continue
- Page 169 and 170: Faculty Disclosure Listing continue
- Page 171 and 172: Faculty Disclosure Listing continue
- Page 173 and 174: you to attend thethe Innovations Th
- Page 175 and 176: 5.5 HyperkalemiaIncreases in serum
- Page 177 and 178: with Pgp substrates or weak to mode
- Page 179 and 180: Valturna (aliskiren and valsartan,
- Page 181 and 182: 4 CONTRAINDICATIONSNone.5 WARNINGS
- Page 183 and 184: een reported. In a 4-day trial of v
- Page 185 and 186: 7 DRUG INTERACTIONSNo drug interact
- Page 187 and 188: 8.5 Geriatric UseIn 8.5the Geriatri
- Page 189 and 190: 2010 ASH ExhibitorsASH Hypertension
- Page 191 and 192: ASH Hypertension Resource CenterHil
- Page 193 and 194: 2010 ASH Exhibitors continuedCVRx I
- Page 195 and 196:
2010 ASH Exhibitors continuedIntern
- Page 197 and 198:
2010 ASH Exhibitors continuedNature
- Page 199 and 200:
2010 ASH Exhibitors continuedRESPeR
- Page 201 and 202:
Author IndexAAbaunza, Ricardo, 122A
- Page 203 and 204:
Author IndexCastellano, Maurizio, 1
- Page 205 and 206:
Author IndexGuarneri, Marco, 146Guo
- Page 207 and 208:
Author IndexLekakis, John, 118, 122
- Page 209 and 210:
Author IndexPittaras, Andreas, 149P
- Page 211 and 212:
Author IndexTello, Susana, 109, 135
- Page 213 and 214:
Hilton New York Floor PlansSecond F
- Page 215 and 216:
Hilton New York Floor PlansFourth F
- Page 218:
Are You 1in 3?Get the facts. Know y